BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4148434)

  • 1. Letter: Effects of 5,6-dihydroxytryptamine on the metabolism of 5-hydroxytryptamine in the central nervous system of the rat.
    Baldessarini RJ; Gerson S
    J Pharm Pharmacol; 1973 Aug; 25(8):647-8. PubMed ID: 4148434
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 5,6-dihydroxytryptamine on nerve terminal serotonin and serotonin uptake in the rat brain.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Apr; 53(1):117-27. PubMed ID: 4697240
    [No Abstract]   [Full Text] [Related]  

  • 3. Accumulation and disappearance of 3 H-5-hydroxytryptamine formed in vivo from 3 H-tryptophan in various regions of the rat brain.
    Schubert J; Sedvall G
    Eur J Pharmacol; 1972 Jan; 17(1):75-80. PubMed ID: 5016584
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of neonatal 5,7-dihydroxytryptamine treatment on the development of serotonin neurons and their transmitter metabolism.
    Ponzio F; Jonsson G
    Dev Neurosci; 1978; 1(2):80-9. PubMed ID: 755684
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat.
    Björklund A; Baumgarten HG; Lachenmayer L; Rosengren E
    Cell Tissue Res; 1975 Aug; 161(2):145-55. PubMed ID: 1175203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-specific actions of dihydroxylated tryptamines in the central nervous system of the rat.
    Gerson S; Baldessarini RJ
    J Pharm Pharmacol; 1974 Jan; 26(1):71-3. PubMed ID: 4150942
    [No Abstract]   [Full Text] [Related]  

  • 7. A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat.
    Kety SS; Javoy F; Thierry AM; Julou L; Glowinski J
    Proc Natl Acad Sci U S A; 1967 Sep; 58(3):1249-54. PubMed ID: 5233846
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.
    Baumgarten HG; Evetts KD; Holman RB; Iversen LL; Vogt M; Wilson G
    J Neurochem; 1972 Jun; 19(6):1587-97. PubMed ID: 4402486
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased synthesis and utilization of serotonin in the central nervous system of the rat during paradoxical sleep deprivation.
    Hery F; Pujol JF; Lopez M; Macon J; Glowinski J
    Brain Res; 1970 Jul; 21(3):391-403. PubMed ID: 4318998
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A
    Acta Physiol Scand Suppl; 1973; 391():1-19. PubMed ID: 4521070
    [No Abstract]   [Full Text] [Related]  

  • 11. Degenerative effects of various neurotoxic indoleamines on central monoamine neurons.
    Nobin A; Björklund A
    Ann N Y Acad Sci; 1978 Jun; 305():305-27. PubMed ID: 360938
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effects of 5,7-dihydroxytryptamine on brain monoamines.
    Jacoby JH; Lytle LD; Nelson MF
    Life Sci; 1974 Mar; 14(5):909-19. PubMed ID: 4828406
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of norepinephrine in the central nervous system by theophylline and caffeine.
    Berkowitz BA; Tarver JH; Spector S
    Eur J Pharmacol; 1970 Apr; 10(1):64-71. PubMed ID: 5458986
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperthermia and elevated brain 5-hydroxytryptamine of rabbits in response to tryptophan and 5-hydroxytryptophan infusion.
    Weber LJ; Angell LA
    Biochem Pharmacol; 1967 Dec; 16(12):2451-4. PubMed ID: 5299746
    [No Abstract]   [Full Text] [Related]  

  • 15. Action of probenecid on the central nervous system of the rabbit. I. Effects on the elimination of 5-hydroxyindoleacetic acid.
    Gardey-Levassort C; Olive G; Sadeghi D; Lechat P
    Pharmacology; 1973; 9(2):107-14. PubMed ID: 4268269
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A; Stenevi U
    Acta Physiol Scand Suppl; 1971; 373():1-15. PubMed ID: 5291907
    [No Abstract]   [Full Text] [Related]  

  • 18. Opposed behavioral syndromes in rats with partial and more complete central serotonergic lesions made with 5,6 dihydroxytryptamine.
    Diaz J; Ellison G; Masuoka D
    Psychopharmacologia; 1974 Jun; 37(1):67-79. PubMed ID: 4414929
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines.
    Horn AS; Baumgarten HG; Schlosserberger HG
    J Neurochem; 1973 Jul; 21(1):233-6. PubMed ID: 4720899
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of effect of neuropharmacological drugs. VI.: Effect of noradrenaline and 5-hydroxytryptamine on brain free fatty acids.
    Sklenovský A; Chmela Z; Rypka M
    Act Nerv Super (Praha); 1979 Oct; 21(3):169-70. PubMed ID: 517094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.